Business Wire

Hon’ble Chief Minister Shri Yogi Adityanath Ji Unveils HCL’s Biggest CSR Initiative – ‘Samuday’

Del

Hon’ble Chief Minister of Uttar Pradesh Shri Yogi Adityanath Ji today unveiled HCL Foundation’s biggest corporate social responsibility (CSR) initiative called ‘Samuday’- a rural development initiative to create model villages, which has touched lives of around six lac people in the state.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171107005823/en/

Hon'ble CM, Uttar Pradesh, Shri Yogi Adityanath Ji at the HCL Samuday unveiling ceremony along with  ...

Hon'ble CM, Uttar Pradesh, Shri Yogi Adityanath Ji at the HCL Samuday unveiling ceremony along with Mr. Shiv Nadar, Founder & Chairman, HCL & Shiv Nadar Foundation; Roshni Nadar Malhotra, CEO, HCL Corporation; Dy CM, Uttar Pradesh, Dr. Dinesh Sharma; State Minister IT & Electronics, Mohsin Raza and Navpreet Kaur, Director, HCL Samuday and some of the Samuday beneficiaries (Photo: Business Wire)

HCL Foundation, the CSR arm of HCL Technologies, launched Samuday in 2015. Currently the project is being implemented in three blocks of Hardoi district of Uttar Pradesh. Since its launch, Samuday has impacted around six lac people in 90,000 households across 720 villages through interventions in fields of education, agriculture, livelihood, health, infrastructure, water & sanitation.

Speaking on the occasion, Hon’ble Chief Minister of Uttar Pradesh, Shri Yogi Adityanath Ji, said, “I congratulate HCL for launching ‘Samuday’ in Uttar Pradesh. It makes me proud that HCL, which started its journey from Uttar Pradesh and is now grown into a global conglomerate, has chosen Uttar Pradesh for its biggest CSR project. I am confident that the spirit with which the project is being implemented will certainly help the last man on the ground.”

In a little over two years, Samuday has set up over 380 ICT-based classrooms and enrolled 1865 people for adult literacy programme. Samuday has also engaged 5000 farmers under various interventions and constructed 5500 toilets, which are currently under usage. In addition, 49 mini solar grids are being set–up across 63 villages. The Foundation has supported 2000 pregnant females and 7000 severely malnourished children.

“We, at HCL Foundation, believe that positive social change can be brought by innovative and creative models of development. Our proximity to the place from where we started our journey makes Uttar Pradesh the right fit for the project to begin. We feel that through the Samuday model, we will be able to develop a blueprint that is sustainable, scalable and replicable throughout the world,” said Roshni Nadar Malhotra, Chief Executive Officer, HCL Corporation and Chairperson of the CSR Committee for the HCL Technologies Board.

“HCL Samuday will help us bring a positive impact through its various interventions in the areas of Education, Livelihood, Health, Infrastructure, Wash & Sanitation and Agriculture. We thank Uttar Pradesh government for their continued encouragement and support,” said Navpreet Kaur, Director, Project–Samuday.

For more information: visit http://www.hcl.com/hcl-foundation

Contact information

HCL
Shruti Roy
shruti.roy@hcl.com
or
Ajay Davessar
ajay.davessar@hcl.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Alibaba Cloud Expands European Presence With UK Data Centres22.10.2018 08:00Pressemelding

Alibaba Cloud, the cloud computing arm of Alibaba Group, has today announced the opening of two availability zones in the UK, in addition to its Frankfurt and Dubai data centres launched in 2016. This expansion not only extends Alibaba Cloud’s capabilities within Europe, but also serves to highlight the provider’s ongoing commitment to the region. Alibaba Cloud’s local footprint is steadily increasing, with data centres across three EMEA locations: Frankfurt, Dubai, and now London. Answering an increase in demand for Alibaba Cloud services across the EMEA region, the pair of high performance availability zones will enable organisations in the region to accelerate the upgrade of their digital infrastructure enabling more efficient digital transformation initiatives. Business continuity is also a clear focus, with dual availability zones offering stronger disaster recovery capabilities. The London location also boasts 24/7 on-site support – including both security and engineering – as we

New Three-Year Data for Janssen’s TREMFYA®▼ (Guselkumab) Demonstrates Well Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis22.10.2018 08:00Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new long-term data from the open-label period of the VOYAGE 1 clinical study. The data demonstrate well maintained rates of skin clearance with TREMFYA®▼ (guselkumab) treatment at Week 52 (1 year) and Week 156 (3 years) among adult patients with moderate to severe plaque psoriasis.1 The findings, presented at the 37th Fall Clinical Dermatology Conference in Las Vegas, USA, showed nearly 83 percent of patients receiving guselkumab in the Phase 3 VOYAGE 1 study maintained at least a 90 percent improvement in the Psoriasis Area Severity Index (PASI 90), or near complete skin clearance, and an Investigator’s Global Assessment (IGA) score of cleared (0) or minimal disease (1) at Week 156.1 “These findings are impressive as they demonstrate consistency in high rates of skin clearance with guselkumab treatment at Weeks 48, 100 and 156, with every eight-week maintenance therapy,” said Andrew Blauvelt, MD, MBA, President,

Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®▼ (Tivozanib) for Patients with Advanced Renal Cell Carcinoma22.10.2018 07:51Pressemelding

EUSA Pharma (EUSA) welcomes the news that FOTIVDA®▼ (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology (ESMO) clinical practice guidelines for advanced renal cell carcinoma (aRCC), anticipated to be published at the end of this year.1 The outline of the new proposed guidelines was presented on 19th October at the annual ESMO 2018 Congress in Munich, Germany, and indicated that tivozanib will be included as a first-line treatment recommendation for aRCC clear cell histology patients. The update will position tivozanib as a treatment standard for good (or favourable) risk patients with a Class IIa recommendation, and a treatment option for intermediate risk patients with a Class IIb recommendation.1 The indication of inclusion of tivozanib in the ESMO guidelines follows the grant of a European Commission (EC) licence in August 2017 for this oral, once-daily,a potent selective vascular endothelial growth factor receptor tyrosine kinase inhibitors (

Open Fiber Powers Its Optical Network With SM Optics WDM ROADM22.10.2018 07:00Pressemelding

Open Fiber a national wholesales operator awards SM Optics, part of SIAE MICROELETTRONICA group a contract to supply and deploy WSS-free WDM ROADM technology extending fibre connectivity from their fibre backbone to metro/regional sites. The new network transports the FTTH (fibre-to-the-home) and FWA (Fixed-wireless-access) aggregated traffic, delivering ultra-broadband service to houses and local businesses. Open Fiber mission is to build a nationwide fiber network, bringing fibre connectivity to the vast majority of households and enterprises in the country, with a target of almost 19 million property units. This optical access infrastructure will enable operators delivering next generation services from FTTH broadband network for data, gaming, video streaming and mobile connectivity to 5G and IoT. SM Optics optical transport solution offers unprecedented flexibility in the smallest footprint, successfully meeting the challenge of limited space deployment and low power consumption. F

Zscaler Extends Cloud DLP Service with Inline Exact Data Match for Massive Data Sets Covering Users Globally22.10.2018 06:30Pressemelding

Zenith Live Europe – Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced inline Exact Data Match (EDM) with native SSL inspection as part of its advanced Cloud Data Loss Prevention (DLP) service. The inline EDM capability extends the Zscaler™ cloud platform to protect against the loss of sensitive information across all users and branches with more precision while reducing the number of false positives to near zero. This service is provided in the Zscaler cloud, providing the capacity of one billion data points per customer across 100 data centers globally. Traditional DLP appliances that sit in the data center are expensive and resource-intensive, and their protection can be subpar, often failing to alert an organization until after data has been compromised. Zscaler’s inline EDM with native SSL inspection blocks sensitive information before it leaves the network. In the first half of 2018, the Zscaler cloud platform blocked an average of 800,000 SSL-encrypted tr

Vivior Chairman Receives Award for Outstanding Contributions to Refractive Surgery22.10.2018 06:00Pressemelding

Michael Mrochen, PhD, Chairman of the Board of Directors at Vivior, receives the Casebeer Award from the International Society of Refractive Surgery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181021005012/en/ Michael Mrochen, PhD Chairman of the Board of Directors Vivior AG (Photo: Business Wire) The International Society of Refractive Surgery (ISRS), a partner of the American Academy of Ophthalmology, is the leading worldwide organization for refractive surgeons. Each year, ISRS awards members for their special contributions to the ISRS, as well as their dedication to the field. The Casebeer Award recognizes an individual for his or her outstanding contributions to refractive surgery through nontraditional research and development activities (https://www.isrs.org/about-isrs/awards). Michael Mrochen is internationally known for his pioneering work on corneal laser surgery, corneal cross linking, ocular biometry and corn